Literature DB >> 10147248

Obesity in Europe: prevalence and consequences for use of medical care.

J C Seidell1, I Deerenberg.   

Abstract

Obesity {defined herein as a body mass index (BMI) greater than 30 kg/m2} is common in middle-aged Europeans, particularly in women from Mediterranean and Eastern European countries. Epidemiological comparison shows no relationship between obesity and coronary heart disease mortality in men, but a weak association in women, which became stronger after adjustment for smoking. Within individual countries, however, increased BMI is associated with increased cardiovascular risk factors in populations across Europe. In The Netherlands, the direct annual healthcare costs associated with overweight and obesity (BMI greater than 25 kg/m2) have been calculated to be approximately 1 billion Dutch guilders, which corresponds to about 4% of total healthcare costs.

Entities:  

Mesh:

Year:  1994        PMID: 10147248     DOI: 10.2165/00019053-199400051-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  8 in total

1.  The production of health and the demand for health care in Finland.

Authors:  U Häkkinen
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

2.  Body fat distribution in relation to serum lipids and blood pressure in 38-year-old European men: the European fat distribution study.

Authors:  J C Seidell; M Cigolini; J P Deslypere; J Charzewska; B M Ellsinger; A Cruz
Journal:  Atherosclerosis       Date:  1991-02       Impact factor: 5.162

3.  Indicators of fat distribution, serum lipids, and blood pressure in European women born in 1948--the European Fat Distribution Study.

Authors:  J C Seidell; M Cigolini; J Charzewska; B M Ellsinger; G Di Biase; P Björntorp; J G Hautvast; F Contaldo; V Szostak; L A Scuro
Journal:  Am J Epidemiol       Date:  1989-07       Impact factor: 4.897

4.  WHO MONICA Project: assessing CHD mortality and morbidity.

Authors:  J Tuomilehto; K Kuulasmaa
Journal:  Int J Epidemiol       Date:  1989       Impact factor: 7.196

5.  A prospective study of obesity and risk of coronary heart disease in women.

Authors:  J E Manson; G A Colditz; M J Stampfer; W C Willett; B Rosner; R R Monson; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1990-03-29       Impact factor: 91.245

6.  WHO MONICA Project: risk factors.

Authors:  U Keil; K Kuulasmaa
Journal:  Int J Epidemiol       Date:  1989       Impact factor: 7.196

7.  Associations of moderate and severe overweight with self-reported illness and medical care in Dutch adults.

Authors:  J C Seidell; L C de Groot; J L van Sonsbeek; P Deurenberg; J G Hautvast
Journal:  Am J Public Health       Date:  1986-03       Impact factor: 9.308

8.  Longevity of man: relative weight and fatness in middle age.

Authors:  A Keys
Journal:  Ann Med       Date:  1989-06       Impact factor: 4.709

  8 in total
  12 in total

1.  Epidemiology and consequences of obesity.

Authors:  June Stevens; Kimberly P Truesdale
Journal:  J Gastrointest Surg       Date:  2003 May-Jun       Impact factor: 3.452

2.  Length of hospital stays among obese individuals.

Authors:  Claire Zizza; Amy H Herring; June Stevens; Barry M Popkin
Journal:  Am J Public Health       Date:  2004-09       Impact factor: 9.308

Review 3.  Socioeconomic issues affecting the treatment of obesity in the new millennium.

Authors:  L F Martin; A Robinson; B J Moore
Journal:  Pharmacoeconomics       Date:  2000-10       Impact factor: 4.981

4.  The cost of obesity: the US perspective.

Authors:  A M Wolf; G A Colditz
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

5.  Electrical impedance tomography's correlation to lung volume is not influenced by anthropometric parameters.

Authors:  François Marquis; Nicolas Coulombe; Roberta Costa; Hervé Gagnon; Robert Guardo; Yoanna Skrobik
Journal:  J Clin Monit Comput       Date:  2006-05-11       Impact factor: 2.502

6.  The economics of treating obesity.

Authors:  J Hutton
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

Review 7.  Options for the management of obesity.

Authors:  P L Beales; P G Kopelman
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

8.  The cost of obesity in Canada.

Authors:  C L Birmingham; J L Muller; A Palepu; J J Spinelli; A H Anis
Journal:  CMAJ       Date:  1999-02-23       Impact factor: 8.262

Review 9.  Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.

Authors:  R Davis; D Faulds
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

Review 10.  Sibutramine. A review of its contribution to the management of obesity.

Authors:  W McNeely; K L Goa
Journal:  Drugs       Date:  1998-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.